RRC ID 87403
著者 Tashiro H, Kuwahara Y, Kurihara Y, Yaguchi T, Ban S, Watanabe A, Takahashi K.
タイトル Remarkable response to dupilumab in refractory allergic bronchopulmonary mycosis with a giant mucus plug due to Aspergillus udagawae.
ジャーナル Respir Investig
Abstract Allergic bronchopulmonary mycosis (ABPM) is due to hypersensitivity to fungi, usually Aspergillus fumigatus, that is treated with systemic corticosteroids; it often relapses and causes adverse effects. The first case of ABPM due to Aspergillus udagawae with a giant mucus plug in a 45-year-old man whose disease and plug persisted despite 12 months of prednisolone and itraconazole, complicated by steroid-induced central serous chorioretinopathy, is reported. Changing therapy to dupilumab produced rapid clinical improvement and marked shrinkage of the plug without steroid toxicity. Dupilumab targeting IL-4/IL-13 might offer a steroid-sparing option for ABPM.
巻・号 63(6)
ページ 1037-1041
公開日 2025-11-1
DOI 10.1016/j.resinv.2025.08.002
PII S2212-5345(25)00126-1
PMID 40829197
MeSH Antibodies, Monoclonal, Humanized* / therapeutic use Antifungal Agents / therapeutic use Aspergillosis, Allergic Bronchopulmonary* / drug therapy Aspergillus* / isolation & purification Humans Itraconazole / administration & dosage Male Middle Aged Mucus* Prednisolone / administration & dosage Prednisolone / adverse effects Treatment Outcome
リソース情報
病原真核微生物 Aspergillus udagawae IFM 68389